Lactobacillus plantarum GB LP-1 as a direct-fed microbial for neonatal calves

Encapsulated sodium butyrate without or with a botanical extract for transitioning neonatal calves

Butyrate (C4) is known to enhance ruminal papillae development for transitioning neonatal calves from liquid to dry feed, and botanical extracts (BE) have demonstrated enhanced DMI and improved gut health. The hypothesis was that these additives, based on their mechanism of action, could be synergistic to neonatal calf growth performance by improving ruminal function for transitioning from liquid milk replacer (MR) to dry calf starter (CS). Eighty 2- to 5-d old Holstein bull calves were randomly assigned to 1 of 4 treatments using a randomized complete block design with a 2 × 2 factorial treatment arrangement with main effects being 2 MR (C4- vs. C4+) and 2 CS (BE- vs. BE+). The 4 individual treatments were (1) calves fed MR and CS without additives (control; C4-BE); (2) calves fed control MR with CS containing BE at 0.05% (496 mg/kg; C4-BE+); (3) calves fed MR with C4 added at 0.3% at feeding time with control CS (C4+BE-); and (4) calves fed MR with C4 and CS with BE added at same the inclusion rates (C4+BE+). Calves were fed 2×/d at 0630 and 1800 h along with ad libitum CS and free choice water. The MR was fed at 0.55 (DM basis) kg/d for d 1 to 14, then increased to 0.82 kg/d for d 15 to 42, and feeding reduced to 0.415 kg/d fed 1×/d for d 42 to 49, with weaning occurring after the 49-d experimental period. Three calves were excluded from data analysis because 2 calves died and 1 was a statistical outlier. The MR× CS interaction was nonsignificant for BW, BW gain, ADG, CS intake, and total DMI. The main MR effect demonstrated calves fed C4+ having greater BW (54.7 and 56.2 kg, for C4- and C4+, respectively), BW gain (29.0 and 31.7 kg), and ADG (591 and 648 g/d), but similar DMI (0.96 and 0.96 kg/d) compared with calves fed C4-. The number of days required for calves to consume 0.9 kg/d CS for 3 consecutive days (47.3 and 45.7 d) as a weaning criterion was lower (P < 0.05) for calves fed C4+ compared with calves fed C4-. The main CS effects for calves fed without or with BE were similar in BW, BW gain, ADG, CS intake, and total DMI. The overall study (0-49 d) feed conversion demonstrated a MR × CS interaction, with calves fed C4-BE- and C4+BE+ being greater than calves fed C4-BE+ with calves fed C4+BE- being intermediate and similar. The MR × CS interaction was nonsignificant for frame measurements, frame measurement gains, and fecal, nasal, and eye and ear scores, and similar for MR or CS main effects when fed without or with C4 and BE. Feeding neonatal calves C4 in the MR improved growth performance by reducing the days to achieve the weaning criteria. The feeding of a BE did not improve growth performance and did not improve growth performance in the presence of C4.

Effects of kefir fermented with or without 1% autolyzed yeast powder on dry matter intake, intestinal permeability, and rumen fermentation profile of Holstein calves

Co-fermenting kefir with Saccharomyces cerevisiae has been shown to enhance the exopolysaccharides (EPS) produced by lactic acid bacteria during fermentation, which may further promote intestinal development in the calf. Four different concentrations (0%, 0.25%, 0.5%, 1%) on a weight/weight basis (g/20 g kefir grain) of either dried, activated distiller's yeast or autolyzed yeast powder were evaluated for EPS optimization in kefir, and inclusion of 1% autolyzed yeast powder resulted in the greatest EPS yield. In a randomized, complete block design, 81 Holstein heifers were enrolled at 3 d of age, blocked by birth weight, and randomized within block to receive either 125 mL salable whole milk (CON), 125 mL of kefir (KEF), or 125 mL of kefir fermented with 1% autolyzed yeast powder (YAK) in milk replacer 1x/d until 28 d of age. Feed intake and health scores were recorded daily for each calf through 1-week postweaning (63 d of age). Growth measurements were recorded weekly until 9 wk. Indigestible markers D-mannitol and Cr-EDTA were administered at 15, 29, and 50 d to a subset of calves (n = 36) and recovered in plasma and serum to measure intestinal permeability. Rumen fluid was collected from calves (n = 35) via gastric tube at 63 ± 2 d to measure pH and VFA concentrations, as well as serum BHB at 14, 28, 42, 56, and 63 d. While health outcomes (diarrhea, respiratory illness, dehydration) were not affected by treatment, supplementation with YAK significantly improved starter DMI and BW in the preweaning period compared with CON and KEF, and postweaning DMI was significantly improved in both KEF and YAK compared with CON. Increased butyrate was observed in rumen fluid of calves fed YAK, though serum BHB was not affected. This work contributes to further understanding kefir as a promoter of gastrointestinal development in calves and the potential benefits of EPS in the developing ruminant.

Effect of Lactiplantibacillus plantarum N-1 and isomaltose-oligosaccharide on promoting growth performance and modulating the gastrointestinal microbiota in newborn Hu sheep

BACKGROUND

Diarrhea is usually observed in newborn Hu lambs, while severe diarrhea may lead to the stunted growth and even death in lambs, necessitating the common practice of antibiotic administration to newborns. In order to explore the application of the effective probiotics and/or prebiotic treatment in animal feed to lessen the recline on antibiotics, 27 newborn of Hu lambs were equally allocated into three groups: control group (Con), probiotics group (Pro) receiving Lactiplantibacillus plantarum N-1 (LPN-1), and synbiotics group (Syn) receiving LPN-1 combined with isomaltose-oligosaccharide (IMO), and raised till 60 days of age.

RESULTS

Compared with the Con, the incidence of severe diarrhea was lower in both two treatment groups, accompanied by a significant reduction in terramycin administration frequency (P < 0.05). The daily feed intake in newborns significantly increased after probiotics or synbiotics treatment (P < 0.05), leading to the substantial increment in average daily gain by 48.28% and heart girth (P < 0.05), as well as enhancements in height (P < 0.01) at 60 days of the age in synbiotics treatment group. Applying probiotics and synbiotics exhibited the enhanced rumen weight (P < 0.05), and synbiotics further promoted the spleen development (P < 0.05). The inclusion of probiotics and synbiotics significantly modified the gut microbial composition of Hu lambs (P < 0.01), with an increase in Butyrivibrio proteoclasticus and Pseudoruminococcus massiliensis, which were associated with starch and sucrose metabolism. Additionally, the Syn group exhibited an upsurge in the number of species associated with amino acid metabolism and cellulolysis, as well as the raised short-chain fatty acids levels in the newborn gut (P < 0.05).

CONCLUSIONS

This study demonstrated that LPN-1 and IMO had an enhanced effect to improve the growth performance and decrease the reliance on antibiotics by promoting the feed intake, balancing the gut microbiota and increasing the short-chain fatty acids content in Hu lambs.

Choice white grease used for manufacturing a protein-encapsulated fat blend source for neonatal calves

Protein-encapsulated fat (PEF) blends are routinely used for manufacturing calf milk replacers (MR). The use of PEF blends improves fat mixability to ensure MR when mixed and fed as a homogeneous solution for neonatal calves. A new alternative PEF based on choice white grease (CWG) has been developed to improve its mixability and solubility to ensure a homogeneous MR solution. The alternative PEF is hypothesized to support similar growth performance (ADG, DMI, and feed efficiency) of neonatal calves and potentially reduce costs. The study objective was to evaluate CWG PEF as an alternative to a standard animal lard-tallow (ALT) PEF blend to mix a MR to be fed to Holstein calves. A total of 40 Holstein bull calves (2-5 d old) were blocked by BW and randomly assigned to 1 of 2 treatments (n = 20/treatment) using a randomized complete block design. The treatments were (1) CWG used to manufacture a PEF blend, and (2) ALT used to manufacture a PEF blend. The PEF blends were then used to manufacture 2 experimental MR. Both MR were formulated to contain a ratio of 22% CP to 20% fat with Met, Lys, Thr, Trp, and Val AA specifications, and fed twice per day along with ad libitum 22% CP mini-pelleted calf starter (CS) and water. The MR were fed at 15% solids at 0630 and 1800 h, fed at 0.567 kg/d for d 1 to 14, increased to 0.85 kg/d for d 15 to 35, and reduced to once per day at 0.425 kg/d for d 36 to 42 to facilitate weaning at 42 d with ad libitum CS fed for the remainder of the 56-d study. Calves fed CWG and ALT PEF blends were similar (P > 0.10) in BW gain (37.4 and 35.9 kg for CWG and ALT, respectively), ADG (679.8 and 652.7 g/d), CS DMI intake (0.69 and 0.67 kg/d), total DMI (1.19 and 1.17 kg/d) and feed conversion (0.559 and 0.543 kg/kg). No significant differences were detected in frame gains and fecal scores among treatments. Choice white grease can be used to manufacture a PEF blend for use in manufacturing MR for feeding neonatal calves by maintaining growth performance and health at potentially lower cost.

Growth performance of neonatal calves fed milk replacer 2 vs. 3 times per day

Several calf studies demonstrated growth advantages when feeding greater protein and/or milk solids amounts, however, studies comparing 2 times per day vs. 3 times per day feeding are limited. The study objective was to evaluate feeding 2 times per day vs. 3 times per day thereby increasing milk solids intake. Forty 2- to 5-d old Holstein bull calves were blocked by body weight (BW) and randomly assigned to 1 of 2 treatments (N = 20/treatment) using a randomized complete block design. Treatments were 1) 2×: milk replacer (MR) fed 2 times per day; and 2) 3×: MR fed 3 times per day for increased solids intake. The MR was fed at 15% solids at 0630 and 1800 hours and the 3rd 3× feeding was at 1200 hours. Calves on 2× were fed MR at 0.567 kg/d for days 1 to 14, increased to 0.85 kg/d for days 15 to 35, and reduced to 1 time per day at 0.425 kg/d for days 36 to 42 to facilitate weaning at 42 d. Calves on 3× were fed MR 0.851 kg/d for days 1 to 14, increased to 1.275 kg/d for days 15 to 35, and reduced to 1 time per day at 0.425 kg/d for days 36 to 42 followed by weaning. Calf starter (CS; amounts and orts weighed daily) and water were offered for ad libitum intake. Initial BW was not a significant covariate and final BW (81.5 and 80.9 kg, for 2× and 3×, respectively) was similar. A treatment-by-week interaction (P < 0.01) indicated variable BW gains during the study with calves fed 3× demonstrating greater BW during weeks 4 (P < 0.10) and 5 (P < 0.05) compared with calves fed 2×. However, BW gains for calves fed 3× were reduced (P < 0.05) during the weaning period resulting in similar BW gains (36.8 and 36.4 kg) at the study end. Intake of CS (0.65 and 0.46 kg/d) was lower (P < 0.04) for calves fed 3× compared with calves fed 2×. Feed conversions (0.64 and 0.58 kg/kg) were greater (P < 0.02) for calves fed 2× compared with 3× fed calves. Calves fed 2× had less (P < 0.01) scours (fecal score = 0; 34.3 and 29.7 d) compared with 3× fed calves. Providing an additional MR feeding demonstrated minimal BW gains due to lower CS intake. Providing greater MR intake using a 3rd daily feeding reduces CS intake that can inhibit transition to dry feed when weaning calves.

Milk replacer galacto-oligosaccharide (GOS) inclusion rates for neonatal calves

Galacto-oligosaccharide (GOS) is a prebiotic isolated from whey. This study evaluated the optimal inclusion rate for improving growth and health performance of neonatal calves. Eighty-eight 2-5-d old Holstein bull calves were blocked by initial BW and randomly allocated to 1 of 4 treatments using a RCBD. Treatments comprised a 22:20 (CP: fat) amino acid balanced milk replacer (MR) with GOS added at the rate of 0 g/d (Control or GOS0), 2 g/d (GOS2), 4 g/d (GOS4), and 8 g/d (GOS8). Calves received 0.283 kg MR in 1.9 L fed 2 x/d for the first 14 d, then increased to 0.42 kg in 2.84 L fed 2x/d through d 35, followed by 0.42 kg MR in 2.84 L fed 1x/d through d 42, followed by weaning. The GOS inclusion rate remained constant as milk volume increased. Calves fed GOS at 2, 4, and 8 g/d demonstrated similar growth performance compared with calves fed GOS0. Calves fed GOS4 demonstrated a carryover effect into post-weaning resulting in a tendency for increased (P < 0.08) BW (82.5, 83.0, 85.3, and 83.1 kg for GOS0, GOS2, GOS4, and GOS8, respectively), BW gains (37.8, 38.2, 41.3 and 38.6 kg), and ADG (687, 696, 751, and 701 g/d). The ADG was increased by 9.3% when feeding calves GOS4 compared with calves fed GOS0. Calf starter DMI was greater at 7 (1.73,1.86, 1.95, and 1.83 kg/d) and 8 (2.34, 2.50, 2.60, 2.49 kg/d) wk of age for calves fed GOS4 compared with calves fed GOS0 with remaining treatments being intermediate and similar. Feed conversion (0.552, 0.529, 0.563, 0.545 kg/kg) was greater for calves fed GOS0 and GOS4 g/d compared with calves fed GOS2 with calves fed GOS8 being intermediate and similar. Body frame gains were similar for calves fed all GOS inclusion rates. A treatment by week interaction at wk 2 indicated that calves fed GOS2 demonstrated greater fecal score = 0 d than calves fed the remaining treatments, indicating less scours. In conclusion, supplementing GOS to a milk replacer at 4 g/d fed to neonatal calves improved growth performance without compromising health conditions.

Holstein calves fed a milk replacer with a direct fed microbial (DFM) and a starter containing a botanical extract or a DFM alone or in combination

Botanical extracts (BE; Apex, Adisseo, North America) have demonstrated enhanced DMI and improved gut health, while direct fed microbials (DFM), such as Lactobacillus acidophilus fermentation product (EX: Excell, Pacer Technology, Inc.), has demonstrated improved gut health and growth performance of growing Holstein calves. The hypothesis was this combination may be synergistic to neonatal calf growth performance and intestinal health. Eighty, 2-5-d old Holstein bull calves were blocked by BW and randomly assigned to one of 8 treatments arranged in a 2 × 4 factorial using a randomized complete block design. The main factors were milk replacer (MR) without (Control) and with EX added at 5 g/d fed and calf starter (CS). The CS containing no additives (Control); CS containing BE at 496 mg/kg; CS containing EX at 2.50 g/kg; and CS containing BE and EX at the same inclusion rates. The MR were fed 2x/d at 0630 and 1800 h along with free choice CS (amounts and orts weighed d) and water. Weaning occurred after d 42 for the 56-d experiment. No MR by CS main effects interactions were detected for BW, ADG, CS intake, total DMI, feed efficiency or body frame gain parameters. The BW gain (38.0 and 39.3 kg for control and EX, respectively) for MR main effect was similar for calves fed both MR, while CS main effects (38.7, 39.7, 39.2, and 37.2 kg for control, BE, EX, and BE&EX, respectively) was similar among all CS. Gains in body length (10.6 and 10.8 cm), hip width (4.5 and 4.5 cm), withers height, (10.5 and 10.6 cm) heart girth (18.6 and 19.9 cm) and body length (9.1 and 7.9 cm) were similar for calves fed both MR, while CS main effects for hip height (10.5, 10.2, 10.3, and 10.9 cm), hip width (4.7, 4.6, 4.4, and 4.3 cm) withers height (10.7, 10.9, 10.3 and 10.6 cm), heart girth (19.9, 18.9, 18.9, and 19.4 cm), and body length (11.7, 9.1, 8.3, and 8.4 cm) were similar. Total days of a fecal score = 0 was greater for calves fed Control MR and BE CS compared with calves fed Contol MR and the combination of BE&EX with calves fed the remaining treatments being intermediated and similar. This study demonstrated little calf growth performance and health benefits when feeding a BE or EX alone or in combination compared with calves fed control.

Comparable Evaluation of Nutritional Benefits of Lactobacillus plantarum and Bacillus toyonensis Probiotic Supplementation on Growth, Feed Utilization, Health, and Fecal Microbiota in Pre-Weaning Male Calves

This study was conducted to investigate the impact of probiotic supplementation using Lactobacillus plantarum DSA 20174 and/or Bacillus toyonensis ATCC 55050 on growth performance, blood parameters, hematological measures, and fecal microbiota in pre-weaning Holstein calves. Thirty-two four-day-old male calves with a similar genetic background, weighing an average of 38.27 ± 0.12 kg, were randomly assigned to four groups. The groups consisted of a control group (CON) without supplementation, a group receiving B. toyonensis (BT) at 3 × 109 cfu/calf/day, a group receiving L. plantarum (LP) at 1 × 1010 cfu/calf/day, and a group receiving a combination of LP and BT (LP + BT) at half the dosage for each. The study found that calves supplemented with LP and LP + BT experienced significant improvements in average daily gain and final body weight compared to the control group. The LP + BT group showed the most positive effects on TDMI, starter intake, and CP intake. RBC counts tended to be higher in the probiotic groups, with the LP + BT group having the highest values. The LP + BT group also had higher total protein, albumin, globulin, and hematocrit concentrations. All probiotic groups showed higher serum IgG concentrations. Probiotic supplementation led to increased total bacterial count and decreased levels of E. coli, salmonella, and clostridium. The LP + BT group had a significant decrease in coliform count, while both LP and LP + BT groups had increased Lactobacillus populations. In conclusion, LP + BT probiotic supplement showed the most beneficial effects on growth, feed efficiency, blood constituents, and modulation of fecal microbiota composition.

Effect of Lysinibacillus isolated from environment on probiotic properties and gut microbiota in mice

Soil microorganisms (SM) are primarily involved in organism degradation, plant nitrogen nutrient immobilization, host microorganisms and oxidation. However, research on the effect of soil-derived Lysinibacillus on the intestinal microbiota spatial disparity of mice is lacking. To test the probiotic properties of Lysinibacillus and the spatial disparity on mice intestinal microorganisms, hemolysis test, molecular phylogenetic analysis, antibiotic sensitivity testing, serum biochemical assays and 16S rRNA profiling were applied. The results showed that Lysinibacillus (LZS1 and LZS2) was resistant to two common antibiotics, Tetracyclines and Rifampin, and sensitive to other antibiotics among the 12 antibiotics tested and negative for hemolysis. In addition, the body weight of group L (treatment of Lysinibacillus, 1.0 × 10⁸ CFU/d for 21days) mice was significantly greater than that of the control group; serum biochemical tests showed that the TG and UREA were significantly lower in group L. The spatial disparity of intestinal microorganisms in mice was significant, treatment of Lysinibacillus (1.0 × 10⁸ CFU/d for 21days) reduced the intestinal microbial diversity and decreased the richness of Proteobacteria, Cyanobacteria and Bacteroidetes in mice. Furthermore, Lysinibacillus treatment enhanced Lactobacillus and Lachnospiraceae richness and significantly reduced 6 bacterial genera in jejunum community, reduced 8 bacterial genera, but increased bacteria at the 4 genera level in cecum microorganisms. In conclusion, this study demonstrated spatial disparity of intestinal microorganisms in mice and probiotic potential of Lysinibacillus isolated from soil.

Effects of Milk Replacer-Based Lactobacillus on Growth and Gut Development of Yaks' Calves: a Gut Microbiome and Metabolic Study

The gut microbiota and its metabolic activities are crucial for maintaining host homoeostasis and health, of which the role of probiotics has indeed been emphasized. The current study delves into the performance of probiotics as a beneficial managemental strategy, which further highlights their impact on growth performance, serologic investigation, gut microbiota, and metabolic profiling in yaks' calves. A field experiment was employed consisting of 2 by 3 factorial controls, including two development stages, namely, 21 and 42 days (about one and a half month), with three different feeding treatments. Results showed a positive impact of probiotic supplements on growth performance by approximately 3.16 kg (P < 0.01) compared with the blank control. Moreover, they had the potential to improve serum antioxidants and biochemical properties. We found that microorganisms that threaten health were enriched in the gut of the blank control with the depletion of beneficial bacteria, although all yaks were healthy. Additionally, the gut was colonized by a microbial succession that assembled into a more mature microbiome, driven by the probiotics strategy. The gut metabolic profiling was also changed significantly after the probiotic strategy, i.e., the concentrations of metabolites and the metabolic pattern, including enrichments in protein digestion and absorption, vitamin digestion and absorption, and biosynthesis of secondary metabolites. In summary, probiotics promoted gut microbiota/metabolites, developing precise interventions and achieving physiological benefits based on intestinal microecology. Hence, it is important to understand probiotic dietary changes to the gut microbiome, metabolome, and the host phenotype. IMPORTANCE The host microbiome is a composite of the trillion microorganisms colonizing host bodies. It can be impacted by various factors, including diet, environmental conditions, and physical activities. The yaks' calves have a pre-existing imbalance in the intestinal microbiota with an inadequate feeding strategy, resulting in poor growth performance, diarrhea, and other intestinal diseases. Hence, targeting gut microbiota might provide a new effective feeding strategy for enhancing performance and maintaining a healthy intestinal environment. Based on the current findings, milk replacer-based Lactobacillus feeding may improve growth performance and health in yaks' calves.

Characterization of Lactic Acid-Producing Bacteria Isolated from Rumen: Growth, Acid and Bile Salt Tolerance, and Antimicrobial Function

Lactic acid bacteria are some of the dominant bacteria in the rumen, and they have a high ability for lactic acid production. The present study aimed to screen and evaluate the performance of culturable rumen bacteria from Chinese Holstein dairy cows as a potential probiotic or inoculant for silage production, in order to isolate ruminal lactic acid bacteria and evaluate their potential as probiotics. Three strains of Enterococcus avium (E. avium, EA1-3); three strains of Streptococcus lutetiensis (S. lutetiensis, SL1-3); and six strains of Streptococcus equinus (S. equinus, SE1-6) were successfully identified from the rumen fluid using modified De Man Rogosa sharp medium supplemented with 0.325% lactic acid. E. avium, S. lutetiensis and S. equinus are clustered in the phylogenetic tree. All the 12 Gram-positive strains reached the plateau growth phase in 6–10 h, with an OD600 at about 1.8. Both gas and acid accumulation reached plateaus at about 10–12 h in all strains, and S. equinus showed the strongest capacity. The highest lactic acid accumulation was detected in S. equinus broth (up to 219.77 μmol/L). The growth of all isolates was inhibited at pH 4.0, and EA2, SL1, SL2, SL3 and SE2 were tolerant to 0.1%, 0.2% and 0.3% bile salt. In addition, the supernatants of the strains had inhibitory effects on Escherichia coli and Staphylococcus aureus. Specifically, the S. equinus strains exhibited the strongest inhibition of the pathogens. In conclusion, these 12 strains had good potential as silage inoculants or probiotics for edible animals, especially S. equinus.

Impact of a live bacterial-based direct-fed microbial (DFM) postpartum and weaning system on performance, mortality, and health of Najdi lambs

Among the non-nutritive additives available for lamb nutrition, direct-fed microbial (DFM) stands out for altering rumen fermentation and increasing animal productivity. This study was conducted to evaluate the effects of DFM and weaning systems on performance, mortality, and health of newborn lambs. A total of 60 newborn lambs were divided into 4 equal groups and assigned to one of 4 treatments: Control (C) without DFM and late weaning; T1, DFM and early weaning; T2, DFM and mid weaning; and T3, DFM and late weaning. Each lamb in the treated group received 3 doses of DFM (5 mL/lamb). The mortality was reduced by 80% compared to the control group. Lambs in the T2 and T3 with DFM groups had significantly (P < 0.05) higher body weight (BW) and body weight gain (BWG) than lambs in the C group. Glucose, creatinine, and urea nitrogen levels of T3 lambs were significantly (P < 0.05) higher in late weaning compared with the remining treatments. DFM supplementation and weaning system significantly (P < 0.01) reduced serum Zn concentration. These results suggest that the addition of DFM to the diet of newborn lambs and weaning at 60 days improves the overall performance and immunity of the lambs and consequently reduces the mortality rate.

Effects of a multi-strain probiotic on growth, health, and fecal bacterial flora of neonatal dairy calves

OBJECTIVE

The aim of this study was to investigate the effects of dietary supplementation with a multi-strain probiotic (MSP) product containing of Bifidobacterium animalis, Lactobacillus casei, Streptococcus faecalis, and Bacillus cerevisiae on growth, health, and fecal bacterial composition of dairy calves during the first month of life.

METHODS

Forty Holstein calves (24 female and 16 male) at 2 d of age were grouped by sex and date of birth then randomly assigned to 1 of 4 treatments: milk replacer supplementation with 0 g (0MSP), 2 g (2MSP), 4 g (4MSP), and 6 g (6MSP) MSP per calf per day.

RESULTS

Supplementation of MSP did not result in any significant differences in parameters of body measurements of calves during the 30 d period. As the dosage of MSP increased, the average daily gain (p = 0.025) and total dry matter intake (p = 0.020) of calves showed a linear increase. The fecal consistency index of the 2MSP, 4MSP, and 6MSP group calves were lower than that of the 0MSP group calves (p = 0.003). As the dosage of MSP increased, the concentrations of lactate dehydrogenase (p = 0.068) and aspartate aminotransferase (p = 0.081) in serum tended to decrease, whereas the concentration of total cholesterol increased quadratically (p = 0.021). The relative abundance of Dorea in feces was lower (p = 0.011) in the 2MSP, 4MSP, and 6MSP group calves than that in the 0MSP group calves. The relative abundance of Dorea (p = 0.001), Faecalibacterium (p = 0.050), and Mitsuokella (p = 0.030) decreased linearly, whereas the relative abundance of Prevotella tended to increase linearly as the dosage of MSP increased (p = 0.058).

CONCLUSION

The MSP product can be used to reduce the diarrhea, improve the performance, and alter the composition of the fecal bacteria in neonatal dairy calves under the commercial conditions.

Changes in immune system and intestinal bacteria of cows during the transition period

•

Transitional high-energy diets reduce peripheral blood lymphocytes in dairy cows.

•

High-energy diets upregulate IL-1β and IL-2 and downregulate IL-10 expression.

•

Functional lactobacillus plantarum LP1 restores normal levels of lymphocytes subset.

•

Lactobacillus plantarum LP1-added diets reduce inflammatory cytokine expression.

•

LP1 mitigates immune response imbalances caused by transitional high energy diets.

High-yield dairy cows need high energy feed during periods of increased milk production. The transitional feeding to high energy feed increases the risk of developing a variety of metabolic disorders. Here, five Holstein cows were fed a four-stage feeding protocol (3 weeks for each stage) ranging from 54.9 to 73.7% total digestive nutrients (TDN). The purpose of the study was to investigate the effect of lactic acid bacteria on high-energy-fed cows associated with transitional feeding, and to evaluate the effects of probiotics on intestinal bacterial changes and inflammatory responses. Three feed transition periods were established for five cows, and Lactobacillus plantarum RGU-LP1 (LP1) was fed as a probiotic during the high-energy feeding period. The number of lymphocyte subsets such as CD3-, CD4-, and CD8 positive cells decreased in response to the high energy feed. Lipopolysaccharide (LPS)-induced cytokine (IL-1β and IL-2) gene expression in peripheral blood mononuclear cells (PBMCs) was shown to increase in those animals receiving the high energy feed. However, supplementation with LP1 resulted in an increase in the number of lymphocyte subsets and the expression of IL-1β and IL-2 were returned to the level at low energy diet. These results suggest that high energy diets induce inflammatory cytokine responses following LPS stimulation, and that the addition of LP1 mitigates these results by regulating the LPS-induced inflammatory reaction. Therefore, the functional lactic acid bacteria LP1 is expected to regulate inflammation resulting from high energy feeding, and this probiotic could be applied to support inflammatory regulation in high-yield dairy cows.

Implication and challenges of direct-fed microbial supplementation to improve ruminant production and health

Direct-fed microbials (DFMs) are feed additives containing live naturally existing microbes that can benefit animals' health and production performance. Due to the banned or strictly limited prophylactic and growth promoting usage of antibiotics, DFMs have been considered as one of antimicrobial alternatives in livestock industry. Microorganisms used as DFMs for ruminants usually consist of bacteria including lactic acid producing bacteria, lactic acid utilizing bacteria and other bacterial groups, and fungi containing Saccharomyces and Aspergillus. To date, the available DFMs for ruminants have been largely based on their effects on improving the feed efficiency and ruminant productivity through enhancing the rumen function such as stabilizing ruminal pH, promoting ruminal fermentation and feed digestion. Recent research has shown emerging evidence that the DFMs may improve performance and health in young ruminants, however, these positive outcomes were not consistent among studies and the modes of action have not been clearly defined. This review summarizes the DFM studies conducted in ruminants in the last decade, aiming to provide the new knowledge on DFM supplementation strategies for various ruminant production stages, and to identify what are the potential barriers and challenges for current ruminant industry to adopt the DFMs. Overall literature research indicates that DFMs have the potential to mitigate ruminal acidosis, improve immune response and gut health, increase productivity (growth and milk production), and reduce methane emissions or fecal shedding of pathogens. More research is needed to explore the mode of action of specific DFMs in the gut of ruminants, and the optimal supplementation strategies to promote the development and efficiency of DFM products for ruminants.